CoChat
Sign Up
Cited by 924Antioxidant Activity and Oxidative StressVitamin C and Antioxidants ResearchNutrition and Health Studies

The DOI matches its Crossref record; 1,161 of the 1,161 references it cites were found in a registry or an index.

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

Open access
Bjelakovic, Goran, Nikolova, Dimitrinka, Gluud, Lise Lotte, Simonetti, Rosa G, Gluud, Christian·2012·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd007176.pub2PMC PMC8407395
Open this paper in CoChat — free account

Abstract

BACKGROUND: Our systematic review has demonstrated that antioxidant supplements may increase mortality. We have now updated this review. OBJECTIVES: To assess the beneficial and harmful effects of antioxidant supplements for prevention of mortality in adults. SEARCH METHODS: We searched The Cochrane Library, MEDLINE, EMBASE, LILACS, the Science Citation Index Expanded, and Conference Proceedings Citation Index-Science to February 2011. We scanned bibliographies of relevant publications and asked pharmaceutical companies for additional trials. SELECTION CRITERIA: We included all primary and secondary prevention randomised clinical trials on antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, and selenium) versus placebo or no intervention. DATA COLLECTION AND ANALYSIS: Three authors extracted data. Random-effects and fixed-effect model meta-analyses were conducted. Risk of bias was considered in order to minimise the risk of systematic errors. Trial sequential analyses were conducted to minimise the risk of random errors. Random-effects model meta-regression analyses were performed to assess sources of intertrial heterogeneity. MAIN RESULTS: Seventy-eight randomised trials with 296,707 participants were included. Fifty-six trials including 244,056 participants had low risk of bias. Twenty-six trials included 215,900 healthy participants. Fifty-two trials included 80,807 participants with various diseases in a stable phase. The mean age was 63 years (range 18 to 103 years). The mean proportion of women was 46%. Of the 78 trials, 46 used the parallel-group design, 30 the factorial design, and 2 the cross-over design. All antioxidants were administered orally, either alone or in combination with vitamins, minerals, or other interventions. The duration of supplementation varied from 28 days to 12 years (mean duration 3 years; median duration 2 years). Overall, the antioxidant supplements had no significant effect on mortality in a random-effects model meta-analysis (21,484 dead/183,749 (11.7%) versus 11,479 dead/112,958 (10.2%); 78 trials, relative risk (RR) 1.02, 95% confidence interval (CI) 0.98 to 1.05) but significantly increased mortality in a fixed-effect model (RR 1.03, 95% CI 1.01 to 1.05). Heterogeneity was low with an I(2)- of 12%. In meta-regression analysis, the risk of bias and type of antioxidant supplement were the only significant predictors of intertrial heterogeneity. Meta-regression analysis did not find a significant difference in the estimated intervention effect in the primary prevention and the secondary prevention trials. In the 56 trials with a low risk of bias, the antioxidant supplements significantly increased mortality (18,833 dead/146,320 (12.9%) versus 10,320 dead/97,736 (10.6%); RR 1.04, 95% CI 1.01 to 1.07). This effect was confirmed by trial sequential analysis. Excluding factorial trials with potential confounding showed that 38 trials with low risk of bias demonstrated a significant increase in mortality (2822 dead/26,903 (10.5%) versus 2473 dead/26,052 (9.5%); RR 1.10, 95% CI 1.05 to 1.15). In trials with low risk of bias, beta-carotene (13,202 dead/96,003 (13.8%) versus 8556 dead/77,003 (11.1%); 26 trials, RR 1.05, 95% CI 1.01 to 1.09) and vitamin E (11,689 dead/97,523 (12.0%) versus 7561 dead/73,721 (10.3%); 46 trials, RR 1.03, 95% CI 1.00 to 1.05) significantly increased mortality, whereas vitamin A (3444 dead/24,596 (14.0%) versus 2249 dead/16,548 (13.6%); 12 trials, RR 1.07, 95% CI 0.97 to 1.18), vitamin C (3637 dead/36,659 (9.9%) versus 2717 dead/29,283 (9.3%); 29 trials, RR 1.02, 95% CI 0.98 to 1.07), and selenium (2670 dead/39,779 (6.7%) versus 1468 dead/22,961 (6.4%); 17 trials, RR 0.97, 95% CI 0.91 to 1.03) did not significantly affect mortality. In univariate meta-regression analysis, the dose of vitamin A was significantly associated with increased mortality (RR 1.0006, 95% CI 1.0002 to 1.001, P = 0.002). AUTHORS' CONCLUSIONS: We found no evidence to support antioxidant supplements for primary or secondary prevention. Beta-carotene and vitamin E seem to increase mortality, and so may higher doses of vitamin A. Antioxidant supplements need to be considered as medicinal products and should undergo sufficient evaluation before marketing.

Overview

Integrity signals

Registry

Crossref · 10.1002/14651858.cd007176.pub2

Cites

1161 of 1161 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

6 retracted

Flagged first, then by citations

Research works printed but not linked: 26

  1. Pincus, 1997, Alpha-tocopherol and Alzheimer's disease, New England Journal of Medicine, 337, 572, 10.1056/NEJM199708213370814 · DOI
  2. Age-Related Macular Degeneration Study Group, 1996, Multicenter ophthalmic and nutritional age-related macular degeneration study - Part 1: design, subjects and procedures, Journal of the American Optometric Association, 67, 12
  3. Brodkin, 1997, Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET), American Journal of Industrial Medicine, 32, 582, 10.1002/(SICI)1097-0274(199712)32:6<582::AID-AJIM2>3.0.CO;2-S · DOI
  4. Stone, 2000, The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI) - Prevenzione trial on fish oil and vitamin E supplementation in myocardial infarction survivors, Current Cardiology Reports, 2, 445, 10.1007/s11886-000-0059-5 · DOI
  5. Lonn, 2002, Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy, Diabetets Care, 25, 1919, 10.2337/diacare.25.11.1919 · DOI
  6. MRC/BHF Heart Protection Study Collaborative Group, 1999, MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience, European Heart Journal, 20, 725, 10.1053/euhj.1998.1350 · DOI
  7. Li, 1998, Vitamins and minerals in cancer: The Nutrition Intervention Trials in Linxian, China, Medecine Biologie Environnement, 26, 187
  8. Sanjose, 1996, Antioxidants, Helicobacter pylori and stomach cancer in Venezuela, European Journal of Cancer Prevention, 5, 57
  9. Vazquez Martinez, 1998, The SUVIMAX (France) study: the role of antioxidants in the prevention of cancer and cardiovascular disorders, Revista Espanola de Salud Publica, 72, 173
  10. Buring, 1992, The Women's Health Study: rationale and background, The Journal of Myocardial Ischemia, 4, 30
  11. Buring, 1992, The Women's Health Study: summary of study design, The Journal of Myocardial Ischemia, 4, 27
  12. Avery, 2003, Effects of vitamin E supplementation on recovery from repeated bouts of resistance exercise, Journal of Strength and Conditioning Research, 17, 801
  13. Bierenbaum, 1985, The effect of supplemental vitamin E on serum parameters in diabetics, postcoronary and normal subjects, Nutrition Reports International, 31, 1171
  14. Crary, 1987, Antioxidant treatment of macular degeneration of the aging and macular edema in diabetic retinopathy, Southern Medical Journal, 80, 38
  15. Sanjose, 1996, Antioxidants, Helicobacter pylori and stomach cancer in Venezuela, European Journal of Cancer Prevention, 5, 57
  16. Greul, 2002, Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins, Skin Pharmacology and Applied Skin Physiology, 15, 307, 10.1159/000064534 · DOI
  17. Jantti, 1991, Treatment of rheumatoid arthritis with fish oil, selenium, vitamins A and E, and placebo, Scandinavian Journal of Rheumatology, 20, 225
  18. Tam, 2005, Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study, Journal of Rheumatology, 32, 275
  19. Cote, 1997, Prevention de la restenose post-angioplastie par la therapie antioxydante, Annales de Cardiologie et D'Angeiologie, 4, 223
  20. Wesnes, 2003, The effects of a combination of Panax ginseng, vitamins and minerals on mental performance, mood and physical fatigue in nurses working night shifts: a double-blind, placebo controllled trial, Current Topics in Nutraceutical Research, 1, 169
  21. Zhu S Mason J Shi Y Hu Y Li R Wang M The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers - Clinical trial and follow-up for seven years Chinese Journal of Gastroenterology 2002 73 8
  22. Zielinski, 1978, On the treatment of arteriosclerotic retinopathy with Cosaldon A+E, Klinische Monatsblatter fur Augenheilkunde, 173, 857
  23. Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Institute of Medicine. Dietary reference intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids National Academy Press, Washington, DC 2000 1 529
  24. Halliwell, 1998, Free Radicals, 89
  25. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008
  26. Stranges, 2007, Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial, Annals of Internal Medicine, 147, 217, 10.7326/0003-4819-147-4-200708210-00175 · DOI

Cited by

Sorted by citations

See all 924

Related

See all

Metadata

Authors
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C.
Affiliations
  • Medical Faculty, University of Nis; Department of Internal Medicine; Zorana Djindjica 81 Nis Serbia 18000
  • Copenhagen University Hospital (DK)
  • Gentofte Hospital (DK)
  • Ospedale Vincenzo Cervello (IT)
ORCID
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2012-03-14
Volume
2012
Issue
3
Pages
CD007176-CD007176
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
DOI
10.1002/14651858.cd007176.pub2
PMC
PMC8407395
OpenAlex
W2174121794
Cited by
924
References
1,161
Citations by year
2026: 19 · 2025: 35 · 2024: 25 · 2023: 43 · 2022: 47 · 2021: 43 · 2020: 54 · 2019: 46 · 2018: 69 · 2017: 54 · 2016: 59 · 2015: 78 · 2014: 65 · 2013: 95 · 2012: 65
FWCI
10.26
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
Keywords
antioxidant supplements, mortality, beta-carotene, vitamin A, vitamin C, vitamin E, selenium, primary prevention, secondary prevention, healthy adults, disease prevention, trial sequential analysis, risk of bias, heterogeneity, subgroup analysis
MeSH terms
Antioxidants, Ascorbic Acid, Female, Health Status, Humans, Male, Mortality, Primary Prevention, Selenium, Vitamin A, Vitamin E, Randomized Controlled Trials as Topic, beta Carotene, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review